Corporate Information And Statement Of Ifrs Compliance [Abstract]
| Concept |
As at 2021-12-31 |
2021-01-01 to 2021-12-31 |
As at 2020-12-31 |
|---|---|---|---|
| Corporate information and statement of IFRS compliance [abstract] | |||
| Legal form of entity | — |
AB
|
— |
| Country of incorporation | — |
Sverige
|
— |
| Address of entity's registered office | — |
223 70 Lund
|
— |
| Description of nature of entity's operations and principal activities | — |
BioInvent är eꢀ bolag som idenꢁfierar och utvecklar anꢁkroppar
|
— |
| Name of parent entity | — |
BioInvent Internaꢀonal AB (publ)
|
— |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [text block] | — | — | — |
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [abstract] | |||
| Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [line items] | |||
| Current inventories |
16 848
SEK
|
— |
4 079
SEK
|
| Current trade receivables |
370,000
SEK
|
— |
29 920
SEK
|
| Current trade payables |
19 720
SEK
|
— |
16 913
SEK
|